Polypharmacy in Germany
More than 50% of individuals over 65 take five or more medications daily. Particularly alarming is that many of these patients are prescribed medications that may be unsuitable for them.
News
PGXperts aims to contribute to better patient care through individualised medication. Find out about the latest company developments, news and useful articles on the following topics: Drug therapy safety and pharmacogenetics.
Popular articles
Spin-off and closing of seed funding
PGXperts GmbH successfully closes seed funding.
Espacio CPI Salud Extremadura
A benchmark for personalised medication in Europe.
PGXperts on the DMEA 2024
The PGXperts team reflects on a successful exhibition.
News
PGXperts aims to contribute to better patient care through individualised medication. Find out about the latest company developments, news and useful articles on the following topics: Drug therapy safety and pharmacogenetics.
AMTS Stewardship Project at Klinikum Fürth
Deutsches Ärzteblatt published an article in its latest September issue about the successful AMTS Stewardship Project conducted at the Klinikum Fürth from 2020 to 2022. Our AMTS expert, Christine Schnitzer, was part of the interdisciplinary team led by Prof. Dr. Harald Dormann and Prof. Dr. Renke Maas.
Popular articles
Espacio CPI Salud Extremadura
A benchmark for personalised medication in Europe
National Adverse Drug Event Awareness Day
Setting an example for the safety of drug therapy
Personalised medication reduces side effects by 30%
Results of the PREPARE study
All articles
AMTS Stewardship Project at Klinikum Fürth
Deutsches Ärzteblatt published an article in its latest September issue about the successful AMTS Stewardship Project conducted at the Klinikum Fürth from 2020 to 2022. Our AMTS expert, Christine Schnitzer, was part of the interdisciplinary team led by Prof. Dr. Harald Dormann and Prof. Dr. Renke Maas.
PGXperts GmbH receives ISO EN 13485 certification
PGXperts has successfully received certification of its quality management system according to EN ISO 13485:2016 as software manufacturer of medical devices for the provision of information for the verification of pharmacogenetic and pharmacological interactions.
Espacio CPI Salud Extremadura
A benchmark for personalised medication in Europe On On 11 and 12 June 2024, the annual meeting of the Espacio CPI Salud took place in Seville, Spain.
PGXperts on the DMEA 2024
The DMEA has always been a cornerstone for digital health enthusiasts and has once again lived up to its reputation. Stimulating discussions, the exchange of innovative ideas and the immersion in digitalization made this event unforgettable.
PGXperts market transition in the UK
Following our successful participation in the Bridgehead program last year, to plan PGXperts’ market transition to North America, we are delighted to have been selected again this year as one of 20 scale-ups in Europe for the EIT Health Bridgehead programme.